Humana Inc (NYSE:HUM) – Equities researchers at Cantor Fitzgerald raised their FY2019 earnings estimates for shares of Humana in a research note issued to investors on Thursday, August 1st. Cantor Fitzgerald analyst S. Halper now anticipates that the insurance provider will post earnings per share of $17.60 for the year, up from their prior estimate of $17.40. Cantor Fitzgerald also issued estimates for Humana’s FY2020 earnings at $18.85 EPS.
Other equities research analysts also recently issued reports about the company. Zacks Investment Research downgraded Humana from a “hold” rating to a “sell” rating in a report on Thursday, April 11th. Piper Jaffray Companies lifted their target price on Humana from $315.00 to $341.00 and gave the stock an “overweight” rating in a research report on Thursday, August 1st. Barclays decreased their target price on Humana from $351.00 to $327.00 and set an “overweight” rating for the company in a research report on Wednesday, April 17th. ValuEngine upgraded Humana from a “sell” rating to a “hold” rating in a research report on Friday, July 12th. Finally, Morgan Stanley decreased their target price on Humana from $331.00 to $315.00 and set an “overweight” rating for the company in a research report on Friday, July 12th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. Humana has an average rating of “Buy” and a consensus target price of $341.21.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.81. Humana had a return on equity of 22.47% and a net margin of 4.13%. The company had revenue of $16.25 billion for the quarter, compared to the consensus estimate of $15.88 billion. During the same period in the previous year, the business earned $3.96 EPS. Humana’s revenue for the quarter was up 13.9% compared to the same quarter last year.
A number of hedge funds have recently made changes to their positions in the business. Whittier Trust Co. bought a new stake in shares of Humana in the 2nd quarter worth $27,000. Next Capital Management LLC acquired a new stake in shares of Humana during the second quarter worth $27,000. Destination Wealth Management raised its position in shares of Humana by 130.0% during the first quarter. Destination Wealth Management now owns 115 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 65 shares during the period. Advantage Investment Management LLC raised its position in shares of Humana by 287.1% during the second quarter. Advantage Investment Management LLC now owns 120 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 89 shares during the period. Finally, Coastal Investment Advisors Inc. raised its position in shares of Humana by 1,110.0% during the second quarter. Coastal Investment Advisors Inc. now owns 121 shares of the insurance provider’s stock worth $33,000 after purchasing an additional 111 shares during the period. Institutional investors own 92.53% of the company’s stock.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading: Retained Earnings
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.